Rameez Rehman, MD
Vascular & Interventional Radiology · East Meadow, NYNPI 1508251661
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.3%), food and beverage and grants — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Penumbra, Inc. at 57.9% of the total. 2025 is the largest year on record at $3,049, more than ten times the $268 reported in 2020.
Across 33 payments — averaging $169.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$3K
- Sirtex Medical Inc$1K
- Cook Medical LLC$379
- Stryker$271
- Balt USA, LLC$267
- Argon Medical Devices, Inc.$267
- plus $141 from 6 others
What the payments were for
- Grants$2685%
- Travel & lodging$3,21157%
- Food & beverage$2,12038%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 5 | $3,240 |
| Sirtex Medical Inc | 5 | $1,034 |
| Cook Medical LLC | 3 | $379 |
| Stryker | 9 | $271 |
| Balt USA, LLC | 2 | $267 |
| Argon Medical Devices, Inc. | 3 | $267 |
| Boehringer Ingelheim | 1 | $32 |
| Imperative Care, Inc | 1 | $31 |
| Trisalus Life Sciences, Inc. | 1 | $24 |
| Bard Peripheral Vascular, Inc. | 1 | $23 |
| Inari Medical, Inc. | 1 | $17 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$3,240
- LAVA LES (Liquid Embolic System)$973
- Prestige Coil System$267
- CLEANER$118
- Clot Management$114
How this compares
$5,600 in reported general payments places this provider in the 70th percentile of 306 vascular & interventional radiology providers in New York.
See all vascular & interventional radiology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 15 | $1,459 |
Paid to pharmacies, not to this prescriber.
Other vascular & interventional radiology in East Meadow
- Michael DrabkinEast Meadow$17K
- Edward KimNew York$831K
- Gary SiskinAlbany$584K
- Robert LooksteinNew York$515K
- Craig GrebenManhasset$456K
- Anuj MalhotraAlbany$288K
- Rahul PatelNew York$275K
- Aaron FischmanNew York$240K
- Philip MeyersNew York$238K
- Abigail FalkNew York$214K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.